Can TCN2 variants that impair cellular B12 transport cause high homocysteine even with normal or high serum B12?

Clinical evidence

• Genetics and Vitamin B12 Transport: The transcobalamin II protein, encoded by the TCN2 gene, is the critical carrier of vitamin B12 in the bloodstream, delivering active cobalamin to cells via receptor-mediated endocytosis. A common genetic polymorphism, the TCN2 rs1801198 (776C>G) variant, leads to a proline-to-arginine substitution. This substitution decreases the binding affinity of transcobalamin to its cellular receptor (CD320), reducing cellular transport and uptake.
• The "Active B12" Paradox: Standard total serum vitamin B12 tests measure both active B12 (bound to transcobalamin) and inactive B12 (bound to haptocorrin). Up to 80% of circulating B12 is bound to haptocorrin and is biologically unavailable for cellular uptake. Consequently, individuals with TCN2 variants can have normal or even high total serum vitamin B12, mask-shielding a severe intracellular deficiency.

Mechanistic explanations

• Functional Intracellular Deficiency: Once inside the cell, vitamin B12 acts as an essential cofactor for two main enzymes: methionine synthase (which converts homocysteine to methionine) and methylmalonyl-CoA mutase (which converts methylmalonyl-CoA to succinyl-CoA).
• Elevated Homocysteine and MMA: When cellular B12 transport is impaired due to TCN2 variants, intracellular methionine synthase activity drops. This leads to an accumulation of homocysteine. Simultaneously, the lack of intracellular B12 impairs methylmalonyl-CoA mutase, causing an accumulation of methylmalonic acid (MMA). Measuring homocysteine and MMA alongside active holotranscobalamin (holoTC) is therefore a much more reliable indicator of functional B12 status than total serum B12.

Bottom line

• The claim is fully supported by science. Common TCN2 genetic variants (such as rs1801198) reduce cellular vitamin B12 transport and uptake, leading to elevated homocysteine (and MMA) due to functional intracellular deficiency, even when standard serum vitamin B12 levels appear normal or elevated. For patients with suspected functional B12 deficiency, evaluating holotranscobalamin, homocysteine, and MMA is clinically superior to relying on total serum B12.